Flexion Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters

BURLINGTON, Mass., Feb. 18, 2014 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today the closing of its initial